PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-May-2023 Sasol Chemicals opens Research, Development and Analytics Centre of Excellence in Germany Businesswire
03-May-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2023 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023 Businesswire
03-May-2023 Innate Pharma Announces Conference Call and Webcast for Q1 Business Update Businesswire
03-May-2023 Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting Businesswire
02-May-2023 ISS Joins Glass Lewis in Recommending Aurinia Shareholders Vote “FOR” ALL Company Director Nominees at 2023 Annual General Meeting Businesswire
02-May-2023 Russell Budd Recognized as 2023 Trailblazers Plaintiffs’ Lawyer by the National Law Journal Businesswire
02-May-2023 Vesigen Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting Businesswire
02-May-2023 EdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0-based in vivo RNA Editing Therapies in NHP Model at the 26th Annual Meeting of ASGCT via Oral Presentation Businesswire
02-May-2023 ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities Businesswire
02-May-2023 Enanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2023 Businesswire
02-May-2023 Publix Pharmacy wins Retail Specialty Pharmacy Patient Choice Award Businesswire
02-May-2023 Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin) Businesswire
02-May-2023 SpotSee Acquires Marathon Products Businesswire
02-May-2023 AscellaHealth Captures Two Stevie Awards, Recognized as Fastest Growing Company and Marketing Department of the Year by 2023 American Business Awards Businesswire
02-May-2023 NEUPATH HEALTH ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BROKERED OFFERING OF $1.453 MILLION OF SUBORDINATED AND POSTPONED UNSECURED NON-CONVERTIBLE DEBENTURES Businesswire
02-May-2023 Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Lupus Nephritis Businesswire
02-May-2023 EY Announces Teresa Whalen, RPh, CEO of CytoAgents as an Entrepreneur Of The Year® 2023 East Central Award Finalist Businesswire
02-May-2023 Hildred Capital Management Completes Strategic Investment in AleraCare Businesswire
02-May-2023 Dr. Weily Soong Appointed Chief Research Innovation Officer for AllerVie Clinical Research Businesswire